Saratov JOURNAL of Medical and Scientific Research

Qualitative expert assessment of the condition of a patient's ocular fundus in severe and advanced stages of proliferative diabetic retinopathy

Summary:

Objective: comparative qualitative expert assessment of the condition of the patient's fundus in severe and advanced stages of proliferative diabetic retinopathy (PDR). Material and methods. An assessment was made of the developed qualitative criteria for the condition of the fundus in patients with the following stages of PDR: severe-high risk 1 (SHRPDR-1, 32 eyes), severe-high risk 2 (SHRPDR-2, 32 eyes) and advanced (APDR, 34 eyes). The developed criteria (preretinal hemorrhage, fibrosis of the posterior hyaloid membrane, vitreous hemorrhage, etc.) were assessed by one ophthalmic surgeon on a point scale: 1 point — initial changes; 2 — weak, but more pronounced (compared to 1 point) changes; 3 — severity of moderate changes; 4 — pronounced changes. Results. The greatest increase in the average score in the group of patients with APDR (compared with SHRPDR-1 and SHRPDR-2) was established according to the following criteria: fibrovascular tissue in the area of the optic nerve head and along the vascular arcades (2 times), fibrosis of the posterior hyaloid membrane (1.5 times), vitreous hemorrhage (1.4 times); for other criteria, the increase in average score varies from 28 to 93%. At the same time, there is only a tendency for the criteria to worsen between SHRPDR-1 and SHRPDR-2 (p>0.05). Conclusion. A significant deterioration of all criteria was established in patients with APDR compared with SHRPDR-1 and SHRPDR-2.

Bibliography:
1. Neroev VV, Zaytseva OV, Mikhailova LA. Diabetic retinopathy prevalence in the Russian Federation according to all-Russia statistics. Russian Ophthalmological Journal. 2023; 16 (3): 7-11. DOI: 10.21516/2072-0076-2023-16-3-7-11
2. Thomas RL, Halim S, Gurudas S, et al. IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract. 2019; 157 (11): 107840. DOI: 10.1016/j.diabres.2019.107840
3. Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology. 2021; 128 (11): 1580-91. DOI: 10.1016/j.ophtha.2021.04.027
4. Budzinskaia MV, Petrachkov DV, Savochkina OA, Arzhukhanov DD. On classification of diabetic retinopathy. Vestnik Oftalmologii. 2019; 135 (5): 272-7. DOI: 10.17116/oftalma2019135052272
5. Golovin AS, Belikova El. A comparative qualitative assessment of the severity of diabetic retinopathy in patients with stages III, IV and V, requiring hemodialysis, of chronic renal insufficiency. Russian Ophthalmological Journal. 2022;15 (4):18-22. DOI: 10.21516/2072 -0076-2022-15-4-18-22
6. Huang СН, Hsieh YT, Yang СМ. Vitrectomy for complications of proliferative diabetic retinopathy in young adults: Clinical features and surgical outcomes. Graefes Arch Clin Exp Ophthalmol. 2017; 255 (1): 863-71. DOI: 10.1007/ S00417-016-3579-4
7. Chen SN, Chen SJ, Wu TT, et al. Refining vitrectomy for proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2023; 261 (12): 3659-70. DOI: 10.1007/ S00417-023-06134-w
8. Berrocal MH, Acaba-Berrocal L. Early pars plana vitrectomy for proliferative diabetic retinopathy: Update and review of current literature. Curr Opin Ophthalmol. 2021; 32 (3): 203-8. DOI: 10.1097/ICU.0000000000000760
9. Liu Y, Wu N. Progress of nanotechnology in diabetic retinopathy treatment. Int J Nanomedicine. 2021; (16): 1391 — 403. DOI: 10.2147/IJN.S294807
10. Liao M, Wang X, Yu J, et al. Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients. ВМС Ophthalmol. 2020; 20 (1): 416. DOI: 10.1186/sl2886-020-01688-3
11. Kazmierczak K, Zuchowski P, Stafiej J, et al. Functional and structural outcomes and complications after pars plana vitrectomy for severe features of proliferative diabetic retinopathy in type 1 and type 2 diabetes mellitus. PLoS One. 2023; 18 (7): e0288805. DOI: 10.1371/journal.pone.0288805
12. Stewart MW, Browning DJ, Landers MB. Current management of diabetic tractional retinal detachments. Indian J Ophthalmol. 2018; 66 (12): 1751-62. DOI: 10.4103/ijo. IJOJ217J8
13. Nishi К, Nishitsuka К, Yamamoto T, Yamashita H. Factors correlated with visual outcomes at two and four years after vitreous surgery for proliferative diabetic retinopathy. PLoS One. 2021; 16(1):e0244281. DOI: 10.1371/journal.pone.0244281
14. Schreur V, Brouwers J, Van Huet RAC, et al. Long-term outcomes of vitrectomy for proliferative diabetic retinopathy. Acta Ophthalmol. 2021; 99 (1): 83-9. DOI: 10.1111/aos.14482

AttachmentSize
2024_01_013-017.pdf311.82 KB

No votes yet